<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Sidec -- </title>
    <link>http://www.sidec.com/news-events/</link>
    <description>The latest news from Sidec AB.</description>
    <language>en-us</language>
    <copyright>© Copyright Sidec Technologies AB</copyright>
    <docs>http://backend.userland.com/rss</docs>
    <item>
<title><![CDATA[The Protein Tomography™ Award Now Published on Sidec’s Homepage]]></title> <link>http://www.sidec.com/category/2/item/264/</link>
<description><![CDATA[Sidec announces that the application form for the 2008 Protein Tomography™ Award is now available at Sidec’s homepage. The winning application will be offered a Protein Tomography™ study in collaboration with Sidec. A Protein Tomography™ study is typically in the range of 0.1 and 0.5 million Euro and will be funded by Sidec.]]></description>
<pubDate>Tue, 27 May 2008 07:56:36 +0200</pubDate>
</item><item>
<title><![CDATA[Sidec AB expands into new offices]]></title> <link>http://www.sidec.com/category/2/item/263/</link>
<description><![CDATA[Sidec has moved to new 800 m2 (8600 square-foot) facility enabling further growth and recruiting of new staff. During the past 12 months, Sidec has doubled the number of employees by recruiting additional Protein Tomography™ analysts, sales representatives and expanding its Marketing and R&D teams.]]></description>
<pubDate>Tue, 6 May 2008 16:13:00 +0200</pubDate>
</item><item>
<title><![CDATA[Sidec announces the first Protein Tomography™ Award at Sidec’s Executive Forum at PEGS]]></title> <link>http://www.sidec.com/category/2/item/262/</link>
<description><![CDATA[This Award is set up to enable research groups in the biopharmaceutical industry, who have not yet collaborated with Sidec on a Protein Tomography™ study, to get acquainted with Sidec’s ground breaking technology successfully used in cancer drug research. ]]></description>
<pubDate>Thu, 1 May 2008 19:13:00 +0200</pubDate>
</item><item>
<title><![CDATA[PROTEIN TOMOGRAPHY™ REVEALS MOLECULAR MODE OF ACTION OF HUMAX-EGFr]]></title> <link>http://www.sidec.com/category/2/item/261/</link>
<description><![CDATA[<Stockholm, Sweden: April 22, 2008i>Using Protein Tomography™, Sidec investigated in collaboration with Genmab the molecular mode of action of HuMax- EGFr (zalutumumab). In this study Sidec showed that EGFr is flexible and that zalutumumab locks the EGFr into a very compact inactive conformation thereby inhibiting cell signaling and cancer cell growth. </i>]]></description>
<pubDate>Tue, 22 Apr 2008 14:29:09 +0200</pubDate>
</item><item>
<title><![CDATA[Sidec is Granted 4 Million SEK for Vizualisation Project]]></title> <link>http://www.sidec.com/category/2/item/260/</link>
<description><![CDATA[Sidec and its collaborate team have been granted 4 million SEK for the development of “ProViz – Interactive visualization of in situ 3D protein images”<br />
]]></description>
<pubDate>Thu, 21 Feb 2008 08:46:12 +0100</pubDate>
</item><item>
<title><![CDATA[Sidec Receives Second Tranch of  SEK 34.3 million]]></title> <link>http://www.sidec.com/category/2/item/254/</link>
<description><![CDATA[Sidec’s three investors, Industrifonden, Early Bird Venture Capital and Investor Growth Capital, have as of today provided SEK 34.3 million in the second tranch of funding. The capital will allow Sidec to continue its intensive growth and to challenge many of the great opportunities in the pharmaceutical industry.]]></description>
<pubDate>Fri, 21 Dec 2007 13:38:47 +0100</pubDate>
</item><item>
<title><![CDATA[Dr. Fritz Frickel Named Chairman of the Board of Sidec]]></title> <link>http://www.sidec.com/category/2/item/253/</link>
<description><![CDATA[The board of Sidec today announced the election of Fritz Frickel PhD as chairman of the board. ]]></description>
<pubDate>Fri, 9 Nov 2007 16:33:43 +0100</pubDate>
</item><item>
<title><![CDATA[News from Sidec]]></title> <link>http://www.sidec.com/category/10/item/247/</link>
<description><![CDATA[]]></description>
<pubDate>Mon, 17 Sep 2007 11:10:04 +0200</pubDate>
</item><item>
<title><![CDATA[Sidec Technologies secures SEK 68,5 Million in Venture Funding]]></title> <link>http://www.sidec.com/category/2/item/241/</link>
<description><![CDATA[Sidec Technologies AB announced today that it has closed a SEK 68,5 million round of funding led by Earlybird Venture Capital, a German venture capital firm and a new investor in the company. Swedish Investor Growth Capital joined together with Industrifonden, an earlier venture partner. <br />
<br />
<br />
]]></description>
<pubDate>Tue, 8 May 2007 15:12:03 +0200</pubDate>
</item><item>
<title><![CDATA[Sidec´s customer issues press release on new findings. New insights to novel mechanism of action of HuMax-EGFr revealed by Protein Tomography™.]]></title> <link>http://www.sidec.com/category/2/item/239/</link>
<description><![CDATA[This week, Genmab A/S issued a press release, announcing new insights into the novel mechanisms of action of one of their products, HuMax-EGFr (zalutumumab).]]></description>
<pubDate>Wed, 14 Mar 2007 10:15:34 +0100</pubDate>
</item>
  </channel>
</rss>